O43 Three years is the minimal effective duration of sustained clinical remission associated with reduced risk of impaired kidney function and of damage accrual in lupus nephritis

O43 Three years is the minimal effective duration of sustained clinical remission associated with reduced risk of impaired kidney function and of damage accrual in lupus nephritis

ObjectivesTo assess the minimum effective duration of clinical remission capable of protecting against damage accrual and development of impaired kidney function (IKF) in lupus nephritis (LN)MethodsPatients with biopsy-proven LN and at least 5 years follow-up were enrolled in this study. Sustained C...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Lupus science & medicine 2024-03, Vol.11 (Suppl 1), p.A40-A41
Hauptverfasser: Gatto, Mariele, Frontini, Giulia, Calatroni, Marta, Cruciani, Claudio, Iaccarino, Luca, Reggiani, Francesco, Sinico, Renato Alberto, Moroni, Gabriella, Doria, Andrea
Format: Artikel
Sprache:eng
Schlagworte:
Lupus
Oral Presentations
Remission (Medicine)
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:ObjectivesTo assess the minimum effective duration of clinical remission capable of protecting against damage accrual and development of impaired kidney function (IKF) in lupus nephritis (LN)MethodsPatients with biopsy-proven LN and at least 5 years follow-up were enrolled in this study. Sustained Clinical remission (sCR) (henceforth: remission) was defined as eGFR>60 ml/min/1.73m2, proteinuria
ISSN:2053-8790
DOI:10.1136/lupus-2024-el.52